G47.39
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Indication for ASV therapy with AHI>15/h at best CPAP pressure 2. Central apnea/ hypopnea due to TECSA 3. Written informed consent to participate in the study, including a data protection statement.
Exclusion criteria
Exclusion criteria: 1. Indication for NIV or o2 therapy 2. Presence of primary or exclusively central sleep apnea 3. Lack of written informed consent to participate in the study, including a data protection statement. 4. Presence of a contraindication to ASV therapy 5. Participation in another study influencing initiation of PAP therapy regarding device settings or tiration
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Evaluation and comparison of results and characteristics of CPAP and ASV group based on obstructive apnea Index (oAI), central apnea index (cAI), mixed apnea index (mAI), hypopnea index (HI), blood gas analysis and survey results | — |
Primary
| Measure | Time frame |
|---|---|
| Comparison of therapy efficacy of continuous positive airway pressure therapy (CPAP) versus adaptive servoventilation (ASV) group based on apneahypopnea index (AHI) of both groups of therapy control night, as well as diagnosis and CPAP/ ASV titration night | — |
Countries
Germany
Contacts
Helios Kliniken Schwerin